Pfizer and Catalia Health have launched a year-long pilot scheme exploring how patients engage with cute robot companions that use artificial intelligence (AI) to check on symptom managemen
Atomwise and Hansoh Pharma have announced an artificial intelligence (AI) drug discovery deal that could be worth $1.5 billion, the largest US-China collaboration in the field.
Experts in digital health have published guidance on use of artificial intelligence (AI) in healthcare, warning that the technology may not be able to keep up with how medicines are used in